Related Experiment Video

Updated: May 25, 2026

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
07:38

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Published on: September 13, 2016

Controversies in Behçet disease

Denis Wakefield1, Emmett T Cunningham, Ilknur Tugal-Tutkun

  • 1School of Medical Sciences, University of New South Wales, Sydney, Australia. D.Wakefield@unsw.edu.au

Ocular Immunology and Inflammation
|February 14, 2012
PubMed

Insights

Behçet disease (BD) experts show significant disagreements on its clinical features, diagnosis, and treatment. This survey highlights key areas needing further research for better patient management.

Area of Science:

  • Ophthalmology
  • Rheumatology
  • Systemic Vasculitis Research

Background:

  • Behçet disease (BD) is a debilitating systemic vasculitis with ongoing research questions.
  • Understanding BD's epidemiology, pathophysiology, and treatment remains incomplete.
  • Ocular manifestations significantly impact BD patient morbidity.

Purpose of the Study:

  • To survey uveitis experts on critical issues in Behçet disease.
  • To identify expert consensus and disparities in BD clinical features, diagnosis, and treatment.
  • To inform future research directions for Behçet disease management.

Main Methods:

  • A survey was distributed to uveitis experts.
  • Expert opinions on Behçet disease epidemiology, pathophysiology, and treatment were collected.
  • Survey responses were analyzed to identify areas of agreement and disagreement.

Main Results:

  • Significant disparities were found among experts regarding BD.
  • Disagreements were noted in concepts related to clinical features of Behçet disease.
  • Variations in diagnostic criteria and treatment strategies for BD were evident.

Conclusions:

  • Expert consensus on Behçet disease is lacking in several key areas.
  • Further research is needed to address these disparities in BD understanding and care.
  • Standardizing diagnosis and treatment protocols for Behçet disease is crucial.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...